Pattern and associated factors of anti-hepatitis C virus treatment-induced adverse reactions-Reference-Cited by-同舟云学术

Pattern and associated factors of anti-hepatitis C virus treatment-induced adverse reactions

Published:2014-01-03 Issue:3 Volume:13 Page:277-286
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Ravi Saeedeh¹²,Nasiri-Toosi Mohsen³,Karimzadeh Iman¹,Khalili Hossein¹,Ahadi-Barzoki Mehdi⁴,Dashti-Khavidaki Simin¹

Affiliation:

1. Tehran University of Medical Sciences, Department of Clinical Pharmacy, Faculty of Pharmacy, Postal Code: 1417614411, P.O. Box: 14155/6451, Tehran, IR Iran ; ;

2. Islamic Azad University, Department of Clinical Pharmacy, Pharmaceutical Sciences Branch, Tehran, IR Iran

3. Tehran University of Medical Sciences, Department of Gastroenterology, Faculty of Medicine, Tehran, IR Iran

4. Zanjan University of Medical Sciences, Department of Clinical Pharmacy, Faculty of Pharmacy, Zanjan, IR Iran

Publisher

Informa Healthcare

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/14740338.2014.866091

Reference51 articles.

1. Peginterferon alpha-2b plus ribavirin compared with interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C in Saudi patients commonly infected with genotype 4

2. Global epidemiology of hepatitis C virus infection

3. Seroprevalence of hepatitis C virus: the first population-based study from Iran

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of Chronic Hepatitis C Virus Using Direct Acting Antivirals in Geriatric Egyptian Patients;Recent Advances in Anti-Infective Drug Discovery;2021-08

2. Changing epidemiology of patients treated with direct acting antivirals for HCV and persistently high SVR12 in an endemic area for HCV infection in Italy: real-life ‘LIver Network Activity’ (LINA) cohort update results;Expert Review of Gastroenterology & Hepatology;2021-03-02

3. Chronic Hepatitis C in Elderly Patients: Current Evidence with Direct-Acting Antivirals;Drugs & Aging;2018-02

4. Clinical efficacy and tolerability of direct-acting antivirals in elderly patients with chronic hepatitis C;European Journal of Gastroenterology & Hepatology;2017-07

5. Current and Evolving Treatments of Genotype 1 Hepatitis C Virus;Gastroenterology Clinics of North America;2015-12